.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hormonal suppression remains a core strategy for chronic endometriosis-associated pain. Randomized and observational evidence supports progestins such as dienogest for reducing dysmenorrhea and pelvic pain while limiting estrogen-driven endometrial and ectopic-tissue activity. For gynecologists, medical treatment is particularly relevant when fertility is not an immediate priority or when surgery would carry meaningful ovarian or anatomic risk. Long-term adherence and side effects such as irregular bleeding, mood changes or headache need discussion. Medical suppression does not eradicate endometriotic lesions, so symptoms may recur after discontinuation. The treatment plan should therefore be aligned with reproductive goals, disease burden and tolerance of therapy.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Hormonal suppression remains a core strategy for chronic endometriosis-associated pain. Randomized and observational evidence supports progestins such as dienogest for reducing dysmenorrhea and pelvic pain while limiting estrogen-driven endometrial and ectopic-tissue activity. For gynecologists, medical treatment is particularly relevant when fertility is not an immediate priority or when surgery would carry meaningful ovarian or anatomic risk. Long-term adherence and side effects such as irregular bleeding, mood changes or headache need discussion. Medical suppression does not eradicate endometriotic lesions, so symptoms may recur after discontinuation. The treatment plan should therefore be aligned with reproductive goals, disease burden and tolerance of therapy.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
